Weight loss drugs, Alzheimer’s treatments and gene editing: Enormous firsts defined 2023 in pharma

[ad_1] Soumyabrata Roy | Nurphoto | Getty Images Drugmakers are closing out a year when they achieved several historic firsts that will shape the pharmaceutical industry in 2024 and beyond.  … Read More

The weight loss drug boom isn’t over yet — here’s what to expect in the year ahead

[ad_1] George Frey | Bloomberg | Getty Images Weight loss drugs exploded into the public eye this year, and 2024 will bring more change to the evolving market.  The drugs … Read More

If you can’t build the next Ozempic, buy it: Where M&A could be heading in the obesity drug space

[ad_1] Investors are contemplating where and when the next big obesity drug deal will occur. At the moment, Novo Nordisk and Eli Lilly have the growing obesity drug market all … Read More